To Get More Information on Biopreservation Market - Request Sample Report
The Global Biopreservation Market Size was valued at USD 3.5 Billion in 2023 and is expected to reach USD 14.3 Billion by 2032, growing at a CAGR of 17.0% over the forecast period 2024-2032.
The Biopreservation Market is at a massive growth due to increased investment and government policies across the world. The adoption of biopreservation technologies has been significantly driven by government initiatives, especially in areas aligned with healthcare and life sciences. Based on the most recent statistics from the U.S. Department of Health and Human Services (HHS), the U.S. government invested around $2.3 billion for health research in 2023, including biopreservation technologies like tissue preservation and cryopreservation. These investments are to help improve the utility of biopreservation for use in clinical practice and to support the biopreservation of biological specimens for research. Also, the World health Organisation (WHO) has recognized the need for sustainable preservation of biological material to ensure better quality of medical research and better health outcomes around the world.
As biopreservation methods evolve, governments are also enforcing stricter regulatory frameworks to facilitate the preservation of biological materials safely and effectively. Guidelines for biopreservation practices have also been developed by the U.S. Food and Drug Administration (FDA) with particular emphasis on organ transplantation and tissue engineering applications. These regulations coupled with programs such as the NIH funding agenda have also aided the popularization of biopreservation technologies. Recent data from the EU Horizon 2020 framework revealed a total of over €500 million in funding for innovative health technologies (including biopreservation solutions) disbursed just this year, 2023. Such policies and investments generate a solid atmosphere for the growth of the biopreservation market, thus becoming an integral part of the modern healthcare infrastructure. Supported by government initiatives, the biopreservation industry is projected to grow further, and further biopreservation companies will be providing solutions in areas like biobanking, regenerative medicine, and tissue engineering.
Drivers
The growing use of regenerative treatments for chronic diseases and degenerative disorders is expanding the need for biopreservation. Techniques are crucial for preserving cells and tissues, which are essential for the success of these therapies.
Significant investments in biobanks for storing biospecimens, such as stem cells and tissue samples, are fueling market growth.
The development of next-generation cryopreservation technologies and hypothermic storage solutions has made biopreservation more efficient and accessible, enhancing market opportunities.
Increasing demand for regenerative medicine is driving the biopreservation market. Regenerative medicine offers tremendous potential, with emerging therapies relying on the storage of biological material like stem cells, tissues, and organs. Type ROF Regenerative medicine is attracting interest as it has the potential to cure diseases that have been difficult to treat using conventional methods such as neurological disorders, heart disease, and trauma-induced tissue loss. According to the World Stem Cell Clinic report, stem cell treatments are becoming more convenient as medical advancements show better results in the treatment of arthritis, chronic pain, and other conditions. Furthermore, with the increased research activities on tissue engineering and organ regeneration, especially in developing/regional countries, the worldwide stem cell market is also contributing to the growing demand for effective biopreservation technologies.
Storing biological materials under ultra-low temperatures or cryopreservation facilities is particularly essential since it allows the preservation of cells/tissue over a long term without sacrificing the quality of the cell tissue. For example, California Cryobank, one of the pioneers in stem cell storage, has been ramping up its biopreservation efforts to accommodate the expansion of regenerative therapies.
Restraints:
The sophisticated equipment and processes required for biopreservation are expensive, limiting widespread adoption, particularly in low-resource settings.
The process of freezing and thawing biological specimens can lead to tissue damage, affecting the long-term stability of preserved samples.
Emerging low-cost preservation technologies, like room-temperature storage, could potentially limit the market for traditional biopreservation methods.
The high cost of biopreservation technologies is the main factor limiting the biopreservation market. Cryopreservation and cloning are costly, complex processes that require specialized equipment like cryopreservation tanks and temperature-controlled storage systems. Also, these systems require specialized training, and frequent maintenance, both of which increase costs. Consequently, this makes it challenging for smaller labs or institutions with budget restrictions to implement these technologies. Low- and middle-income countries are especially burdened by this economic strain due to less efficient research and medical preservation resources. Additionally, variations in the preservation capabilities from simple preservation methods where cells do not grow to complex extract sub-typing methods exert a financial burden, constituting an obstacle to wider market penetration.
By Product
The global biopreservation market was dominated by the equipment segment in 2023, accounting for a large revenue share of the market at 76%. The major share is due to the importance of biopreservation equipment since biopreservation is a key technology, which plays a major role in the efficient storage and preservation of biological materials at ultra-low temperatures. The essential devices in this segment are freezers, refrigerators, cryogenic storage systems, and liquid nitrogen storage tanks commonly used in biobanking and other types of research. The recent explosion in the utilization of state-of-the-art cryopreservation equipment, especially for cell and tissue storage, is a result of its capability to maintain the structure and function of biological samples.
This dominance was fueled by a surge in demand for biopreservation solutions for use in healthcare, research, and biotechnology. Cryopreservation has recently gained significance in life sciences as well as with the U.S. party politics (medical-engineering-biological marriage-making machine) with the organ transplantation breakthrough. According to the U.S. National Institutes of Health (NIH), the organ transplant space has been growing at a rate of 7.8% each year since 2019; and industry growth has been directly linked with preservation technology advancements. This is further highlighted by the European Commission which has so far invested more than €100 million in biopreservation infrastructure throughout the Horizon 2020 program. Driven by the need for tailored storage conditions for patient-specific biological materials, the advent of personalized medicine has also contributed to the growing demand for advanced biopreservation equipment.
By Application
In 2023, the biobanking segment accounted for the largest share of 69% of the global biopreservation market. Numerous breakthroughs are based on biobanks, organizations that collect, store, and distribute biological samples for research. Such biorepositories are crucial to the advancement of medical research, ranging from genetic disease studies to the delivery of personalized medicine. Finally, the U.S. government has taken notice of the NIH set aside $1.5 billion in 2023 for biobanking efforts. These investments aim to promote better preservation of biological materials so that they remain useful for research into the future.
Furthermore, the regenerative medicine segment is projected to grow at a higher compound annual growth rate (CAGR) during the forecast period. This increase in biopreservation is largely attributed to the growing areas of stem cell research, tissue engineering, and gene therapy where access to well-defined, high-quality biological materials is supported by the use of biopreservation technologies. With applications in everything from degenerative disease to traumatic injury, its rapid growth is supported by government-backed funding initiatives. According to a report by the U.S. Food and Drug Administration (FDA), a fourfold increase has been observed in the number of regenerative medicine therapies approved each year over the past five years, a trend that is expected to continue as technology and regulatory frameworks evolve.
North America captured a 42% share of the global biopreservation market in 2023. Strong healthcare infrastructure, investments through government, and technological advancements in biopreservation solutions are the responsible factors for this leading region. The U.S., in particular, has been a global leader in biopreservation due to its strong biotechnology sector, which receives substantial funding from federal agencies such as the NIH and the Department of Defense.
During the forecast period, the Asia-Pacific area is predicted to record the highest CAGR. The growth is primarily due to rising healthcare improvements, increasing clinical trials, and government support for biotechnology developments. With the proliferation of biotech and healthcare industries in regions such as China, Japan, and India, biopreservation sustainable technologies are gaining momentum in these countries. In 2023, the government of China as part of the “Made in China 2025” funding plan is investing more than $400 million into biotechnology research including biopreservation infrastructure to support drug development and clinical trials and preservation of biological samples. With the ongoing establishment of healthcare and research avenues in this region, the need for biopreservation solutions will increase sharply, making Asia-Pacific a primary growth market.
Do You Need any Customization Research on Biopreservation Market - Enquire Now
In January 2024, The U.S. National Institutes of Health (NIH) announced a new $300 million initiative to further develop biopreservation technologies in service of organ transplantation, and improving how long preserved organs remain viable through sophisticated cryopreservation techniques.
In 2024, Thermo Fisher Scientific launched its latest line of high-performance ultra-low temperature (ULT) freezers, the Thermo Scientific TSX Universal Series. This innovation is a liberating milestone in extending functionality, increasing reliability, reducing sustainment, and enhancing performance.
In 2023, Avantor announced its partnership with Tobin Scientific, a global leader in biopharma cold chain services. The partnership is intended to offer US biopharma clients comprehensive logistics solutions for climate-sensitive storage and transportation in conjunction with sophisticated laboratory relocations and research facility moves.
Service Providers / Manufacturers:
Thermo Fisher Scientific (Thermo Scientific TSX Ultra-Low Freezer, Thermo Scientific CryoSure Cryopreservation System)
Avantor (J.T.Baker® Cryogenic Vials, VWR® Cryopreservation Kits)
Sigma-Aldrich (Merck Group) (CryoStor® Cell Freezing Media, CryoEM™ Cryo-Electron Microscopy Products)
Panasonic Healthcare (ThermoScientific TSX Ultra-Low Freezer, MDF-DU702VX ULT Freezer)
BioCision (CoolBox™ Cryo-Tissue Storage System, BioCision® CoolBox™ CFT)
Haier Biomedical (Haier ULT Freezer, Haier Biomedical ULT Freezer Cabinets)
Sartorius AG (BIOSTAT® STR, Sartorius Cell Culture Media)
B Medical Systems (B Medical Systems ULT Freezer, B Medical Systems Cryo Vials)
Nuaire (NU-954U ULT Freezer, NU-8600 ULT Freezer)
VWR International (VWR® CellFreezing Medium, VWR® Freezing Vials)
Users of Biopreservation
Johns Hopkins University
Harvard Medical School
GSK
Pfizer
Novartis
Bristol-Myers Squibb
Stanford University
Scripps Research
Oxford University
Duke University
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | USD 3.5 Billion |
| Market Size by 2032 | USD 14.3 Billion |
| CAGR | CAGR of 17.0% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product (Equipment {Freezers, Refrigerators, Consumables [Vials, Straws, Microtiter Plates, Bags], Liquid Nitrogen}, Media {Pre-formulated, Home-brew}, Laboratory Information Management System (LIMS)) • By Application (Regenerative Medicine {Cell Therapy, Gene Therapy, Others}, Bio-banking {Human Eggs, Human Sperms, Veterinary IVF}, Drug Discovery) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | Thermo Fisher Scientific, Avantor, Sigma-Aldrich (Merck Group), Panasonic Healthcare, BioCision, Haier Biomedical, Sartorius AG, B Medical Systems, Nuaire, VWR International. |
| Key Drivers | • The growing use of regenerative treatments for chronic diseases and degenerative disorders is expanding the need for biopreservation. Techniques are crucial for preserving cells and tissues, which are essential for the success of these therapies. • Significant investments in biobanks for storing biospecimens, such as stem cells and tissue samples, are fueling market growth. |
| Restraints | • The sophisticated equipment and processes required for biopreservation are expensive, limiting widespread adoption, particularly in low-resource settings. • The process of freezing and thawing biological specimens can lead to tissue damage, affecting the long-term stability of preserved samples. |
Ans: The projected market size for the Biopreservation Market is USD 14.3 billion by 2032.
Ans: The North American region dominated the Biopreservation Market in 2023.
Ans: The CAGR of the Biopreservation Market is 17.0% During the forecast period of 2024-2032.
Ans:
The growing use of regenerative treatments for chronic diseases and degenerative disorders is expanding the need for biopreservation. Techniques are crucial for preserving cells and tissues, which are essential for the success of these therapies.
Significant investments in biobanks for storing biospecimens, such as stem cells and tissue samples, are fueling market growth. This trend is also supported by advancements in regenerative medicine research?.
Ans: The biobanking application segment dominated the Biopreservation Market in 2023 with a 69% revenue share.
Table of Content
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.2 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence (2023)
5.2 Prescription Trends, (2023), by Region
5.3 Drug Volume: Production and usage volumes of pharmaceuticals.
5.4 Healthcare Spending: Expenditure data by government, insurers, and out-of-pocket by patients.
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and supply chain strategies
6.4.3 Expansion plans and new product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Biopreservation Market Segmentation, By Product
7.1 Chapter Overview
7.2 Equipment
7.2.1 Equipment Market Trends Analysis (2020-2032)
7.2.2 Equipment Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.3 Freezers
7.2.3.1 Freezers Market Trends Analysis (2020-2032)
7.2.3.2 Freezers Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.4 Refrigerators
7.2.4.1 Refrigerators Market Trends Analysis (2020-2032)
7.2.4.2 Refrigerators Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.5 Consumables
7.2.5.1 Consumables Market Trends Analysis (2020-2032)
7.2.5.2 Consumables Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.5.3 Vials
7.2.5.3.1 Vials Market Trends Analysis (2020-2032)
7.2.5.3.2 Vials Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.5.4 Straws
7.2.5.4.1 Straws Market Trends Analysis (2020-2032)
7.2.5.4.2 Straws Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.5.5 Microtiter Plates
7.2.5.5.1 Microtiter Plates Market Trends Analysis (2020-2032)
7.2.5.5.2 Microtiter Plates Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.5.6 Bags
7.2.5.6.1 Bags Market Trends Analysis (2020-2032)
7.2.5.6.2 Bags Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.6 Liquid Nitrogen
7.2.6.1 Liquid Nitrogen Market Trends Analysis (2020-2032)
7.2.6.2 Liquid Nitrogen Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Media
7.3.1 Media Market Trends Analysis (2020-2032)
7.3.2 Media Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.3 Pre-formulated
7.3.3.1 Pre-formulated Market Trends Analysis (2020-2032)
7.3.3.2 Pre-formulated Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.4 Home-brew
7.3.4.1 Home-brew Market Trends Analysis (2020-2032)
7.3.4.2 Home-brew Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4 Laboratory Information Management System (LIMS)
7.4.1 Laboratory Information Management System (LIMS) Market Trends Analysis (2020-2032)
7.4.2 Laboratory Information Management System (LIMS) Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Biopreservation Market Segmentation, By Application
8.1 Chapter Overview
8.2 Regenerative Medicine
8.2.1 Regenerative Medicine Market Trends Analysis (2020-2032)
8.2.2 Regenerative Medicine Market Size Estimates and Forecasts to 2032 (USD Billion)
8.2.3 Cell Therapy
8.2.3.1 Cell Therapy Market Trends Analysis (2020-2032)
8.2.3.2 Cell Therapy Market Size Estimates and Forecasts to 2032 (USD Billion)
8.2.4 Gene Therapy
8.2.4.1 Gene Therapy Market Trends Analysis (2020-2032)
8.2.4.2 Gene Therapy Market Size Estimates and Forecasts to 2032 (USD Billion)
8.2.5 Others
8.2.5.1 Others Market Trends Analysis (2020-2032)
8.2.5.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Bio-banking
8.3.1 Bio-banking Market Trends Analysis (2020-2032)
8.3.2 Bio-banking Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3.3 Human Eggs
8.3.3.1 Human Eggs Market Trends Analysis (2020-2032)
8.3.3.2 Human Eggs Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3.4 Human Sperms
8.3.4.1 Human Sperms Market Trends Analysis (2020-2032)
8.3.4.2 Human Sperms Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3.5 Veterinary IVF
8.3.5.1 Veterinary IVF Market Trends Analysis (2020-2032)
8.3.5.2 Veterinary IVF Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 Drug Discovery
8.4.1 Drug Discovery Market Trends Analysis (2020-2032)
8.4.2 Drug Discovery Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Regional Analysis
9.1 Chapter Overview
9.2 North America
9.2.1 Trends Analysis
9.2.2 North America Biopreservation Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.2.3 North America Biopreservation Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
9.2.4 North America Biopreservation Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
9.2.5 USA
9.2.5.1 USA Biopreservation Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
9.2.5.2 USA Biopreservation Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
9.2.6 Canada
9.2.6.1 Canada Biopreservation Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
9.2.6.2 Canada Biopreservation Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
9.2.7 Mexico
9.2.7.1 Mexico Biopreservation Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
9.2.7.2 Mexico Biopreservation Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
9.3 Europe
9.3.1 Eastern Europe
9.3.1.1 Trends Analysis
9.3.1.2 Eastern Europe Biopreservation Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.3.1.3 Eastern Europe Biopreservation Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
9.3.1.4 Eastern Europe Biopreservation Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
9.3.1.5 Poland
9.3.1.5.1 Poland Biopreservation Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
9.3.1.5.2 Poland Biopreservation Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
9.3.1.6 Romania
9.3.1.6.1 Romania Biopreservation Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
9.3.1.6.2 Romania Biopreservation Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
9.3.1.7 Hungary
9.3.1.7.1 Hungary Biopreservation Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
9.3.1.7.2 Hungary Biopreservation Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
9.3.1.8 Turkey
9.3.1.8.1 Turkey Biopreservation Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
9.3.1.8.2 Turkey Biopreservation Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
9.3.1.9 Rest of Eastern Europe
9.3.1.9.1 Rest of Eastern Europe Biopreservation Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
9.3.1.9.2 Rest of Eastern Europe Biopreservation Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
9.3.2 Western Europe
9.3.2.1 Trends Analysis
9.3.2.2 Western Europe Biopreservation Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.3.2.3 Western Europe Biopreservation Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
9.3.2.4 Western Europe Biopreservation Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
9.3.2.5 Germany
9.3.2.5.1 Germany Biopreservation Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
9.3.2.5.2 Germany Biopreservation Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
9.3.2.6 France
9.3.2.6.1 France Biopreservation Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
9.3.2.6.2 France Biopreservation Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
9.3.2.7 UK
9.3.2.7.1 UK Biopreservation Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
9.3.2.7.2 UK Biopreservation Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
9.3.2.8 Italy
9.3.2.8.1 Italy Biopreservation Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
9.3.2.8.2 Italy Biopreservation Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
9.3.2.9 Spain
9.3.2.9.1 Spain Biopreservation Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
9.3.2.9.2 Spain Biopreservation Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
9.3.2.10 Netherlands
9.3.2.10.1 Netherlands Biopreservation Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
9.3.2.10.2 Netherlands Biopreservation Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
9.3.2.11 Switzerland
9.3.2.11.1 Switzerland Biopreservation Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
9.3.2.11.2 Switzerland Biopreservation Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
9.3.2.12 Austria
9.3.2.12.1 Austria Biopreservation Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
9.3.2.12.2 Austria Biopreservation Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
9.3.2.13 Rest of Western Europe
9.3.2.13.1 Rest of Western Europe Biopreservation Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
9.3.2.13.2 Rest of Western Europe Biopreservation Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
9.4 Asia Pacific
9.4.1 Trends Analysis
9.4.2 Asia Pacific Biopreservation Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.4.3 Asia Pacific Biopreservation Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
9.4.4 Asia Pacific Biopreservation Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
9.4.5 China
9.4.5.1 China Biopreservation Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
9.4.5.2 China Biopreservation Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
9.4.6 India
9.4.5.1 India Biopreservation Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
9.4.5.2 India Biopreservation Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
9.4.5 Japan
9.4.5.1 Japan Biopreservation Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
9.4.5.2 Japan Biopreservation Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
9.4.6 South Korea
9.4.6.1 South Korea Biopreservation Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
9.4.6.2 South Korea Biopreservation Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
9.4.7 Vietnam
9.4.7.1 Vietnam Biopreservation Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
9.2.7.2 Vietnam Biopreservation Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
9.4.8 Singapore
9.4.8.1 Singapore Biopreservation Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
9.4.8.2 Singapore Biopreservation Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
9.4.9 Australia
9.4.9.1 Australia Biopreservation Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
9.4.9.2 Australia Biopreservation Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
9.4.10 Rest of Asia Pacific
9.4.10.1 Rest of Asia Pacific Biopreservation Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
9.4.10.2 Rest of Asia Pacific Biopreservation Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
9.5 Middle East and Africa
9.5.1 Middle East
9.5.1.1 Trends Analysis
9.5.1.2 Middle East Biopreservation Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.5.1.3 Middle East Biopreservation Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
9.5.1.4 Middle East Biopreservation Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
9.5.1.5 UAE
9.5.1.5.1 UAE Biopreservation Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
9.5.1.5.2 UAE Biopreservation Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
9.5.1.6 Egypt
9.5.1.6.1 Egypt Biopreservation Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
9.5.1.6.2 Egypt Biopreservation Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
9.5.1.7 Saudi Arabia
9.5.1.7.1 Saudi Arabia Biopreservation Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
9.5.1.7.2 Saudi Arabia Biopreservation Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
9.5.1.8 Qatar
9.5.1.8.1 Qatar Biopreservation Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
9.5.1.8.2 Qatar Biopreservation Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
9.5.1.9 Rest of Middle East
9.5.1.9.1 Rest of Middle East Biopreservation Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
9.5.1.9.2 Rest of Middle East Biopreservation Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
9.5.2 Africa
9.5.2.1 Trends Analysis
9.5.2.2 Africa Biopreservation Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.5.2.3 Africa Biopreservation Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
9.5.2.4 Africa Biopreservation Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
9.5.2.5 South Africa
9.5.2.5.1 South Africa Biopreservation Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
9.5.2.5.2 South Africa Biopreservation Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
9.5.2.6 Nigeria
9.5.2.6.1 Nigeria Biopreservation Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
9.5.2.6.2 Nigeria Biopreservation Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
9.5.2.7 Rest of Africa
9.5.2.7.1 Rest of Africa Biopreservation Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
9.5.2.7.2 Rest of Africa Biopreservation Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
9.6 Latin America
9.6.1 Trends Analysis
9.6.2 Latin America Biopreservation Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.6.3 Latin America Biopreservation Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
9.6.4 Latin America Biopreservation Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
9.6.5 Brazil
9.6.5.1 Brazil Biopreservation Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
9.6.5.2 Brazil Biopreservation Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
9.6.6 Argentina
9.6.6.1 Argentina Biopreservation Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
9.6.6.2 Argentina Biopreservation Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
9.6.7 Colombia
9.6.7.1 Colombia Biopreservation Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
9.6.7.2 Colombia Biopreservation Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
9.6.8 Rest of Latin America
9.6.8.1 Rest of Latin America Biopreservation Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
9.6.8.2 Rest of Latin America Biopreservation Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10. Company Profiles
10.1 Thermo Fisher Scientific
10.1.1 Company Overview
10.1.2 Financial
10.1.3 Products/ Services Offered
110.1.4 SWOT Analysis
10.2 Avantor
10.2.1 Company Overview
10.2.2 Financial
10.2.3 Products/ Services Offered
10.2.4 SWOT Analysis
10.3 Sigma-Aldrich (Merck Group)
10.3.1 Company Overview
10.3.2 Financial
10.3.3 Products/ Services Offered
10.3.4 SWOT Analysis
10.4 Panasonic Healthcare
10.4.1 Company Overview
10.4.2 Financial
10.4.3 Products/ Services Offered
10.4.4 SWOT Analysis
10.5 BioCision
10.5.1 Company Overview
10.5.2 Financial
10.5.3 Products/ Services Offered
10.5.4 SWOT Analysis
10.6 Haier Biomedical
10.6.1 Company Overview
10.6.2 Financial
10.6.3 Products/ Services Offered
10.6.4 SWOT Analysis
10.7 Sartorius AG
10.7.1 Company Overview
10.7.2 Financial
10.7.3 Products/ Services Offered
10.7.4 SWOT Analysis
10.8 B Medical Systems
10.8.1 Company Overview
10.8.2 Financial
10.8.3 Products/ Services Offered
10.8.4 SWOT Analysis
10.9 Nuaire
10.9.1 Company Overview
10.9.2 Financial
10.9.3 Products/ Services Offered
10.9.4 SWOT Analysis
10.10 VWR Interalnation.
10.9.1 Company Overview
10.9.2 Financial
10.9.3 Products/ Services Offered
10.9.4 SWOT Analysis
11. Use Cases and Best Practices
12. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
By Product
Equipment
Freezers
Refrigerators
Consumables
Vials
Straws
Microtiter Plates
Bags
Liquid Nitrogen
Media
Pre-formulated
Home-brew
Laboratory Information Management System (LIMS)
By Application
Regenerative Medicine
Cell Therapy
Gene Therapy
Others
Bio-banking
Human Eggs
Human Sperms
Veterinary IVF
Drug Discovery
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of the Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Product Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Product Matrix which gives a detailed comparison of product portfolio of each company
Geographic Analysis
Additional countries in any of the regions
Company Information
Detailed analysis and profiling of additional market players (Up to five)
The global antibiotics market size was USD 47.23 Billion in 2023 & is expected to reach USD 65.23 billion by 2032 at a CAGR of 3.70%.
Airway Disease Treatment Market was valued at $ 2.23 billion in 2023 and is expected to reach $ 3.54 billion by 2032, growing at a CAGR of 5.29% from 2024-2032.
The mHealth Market size is expected to reach USD 142.94 Bn by 2031, and the base value of the market was valued at USD 62.93 Bn in 2023. The CAGR growth rate was recorded at 10.81% over the forecast period of 2024-2031.
The Sexual Health Products Market Size was valued at USD 118.83 Billion in 2023, and is expected to reach USD 243.83 Billion by 2032, and grow at a CAGR of 8.71% over the forecast period 2024-2032.
The Hip Replacement Market Size was valued at USD 7.7 Bn in 2023 and is expected to reach USD 11.20 Bn by 2031 and grow at a CAGR of 4.8% over the forecast period of 2024-2031.
The Retinal Biologics Market Size was valued at USD 22.5 Billion in 2023 and is expected to reach USD 49.5 Billion by 2032 and grow at a CAGR of 9.2% over the forecast period 2024-2032.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
